More news on personalized medicine, sequencing for HIV research and distributed by Abbott Labs.  Sequencing software will continue to grow.  BD 

NEW YORK (GenomeWeb News) – Celera said today that the US Food and Drug Administration has granted marketing clearance for the firm’s ViroSeq HIV-1 Genotyping System Software v2.8.

The Alameda, Calif.-based firm’s HIV-1 Genotyping System detects mutations in the HIV-1 viral genome that confer resistance. It is used by physicians in monitoring and treating HIV-1 infections.

http://www.genomeweb.com/issues/news/148267-1.html?CMP=OTC-RSS

0 comments :

Post a Comment

 
Top